- Tresiba® is contraindicated during episodes of hypoglycemia and in patients with hypersensitivity to Tresiba® or one of its excipients
Give your patients information on how to use Tresiba® FlexTouch® and how to get savings and support.
Tresiba® (insulin degludec injection) is indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus.
Tresiba® is not recommended for treating diabetic ketoacidosis.